Oobli and Ingredion Announce Partnership as Demand for Sweet Proteins Accelerates
Oobli, the first company to build a sweet protein platform, has announced a partnership with Ingredion to accelerate industry access to healthier sweetener systems. The collaboration aims to combine natural sweeteners like stevia with Oobli's proteins that sweeten. Sweet proteins can be used in various food and beverages, including sodas, baked goods, yogurts, and candies.
The partnership follows Oobli's recent FDA GRAS 'no questions' letters for two sweet proteins (monellin and brazzein), confirming their safety for use in food and beverage products. Oobli has also completed an $18M Series B1 funding round, with new strategic investors including Ingredion Ventures, Lever VC, and Sucden Ventures joining existing investors like Khosla Ventures and Piva Capital.
The companies will showcase their novel sweet treats at Future Food Tech in San Francisco on March 13-14, 2025. Oobli's sweet proteins are produced via fermentation, offering a cost-effective and climate-friendly alternative to traditional sweeteners.
Oobli, la prima azienda a costruire una piattaforma di proteine dolci, ha annunciato una partnership con Ingredion per accelerare l'accesso dell'industria a sistemi di dolcificanti più salutari. La collaborazione mira a combinare dolcificanti naturali come la stevia con le proteine dolci di Oobli. Le proteine dolci possono essere utilizzate in vari alimenti e bevande, tra cui bibite, prodotti da forno, yogurt e caramelle.
La partnership segue le recenti lettere di 'nessuna domanda' GRAS della FDA per due proteine dolci (monellina e brazzeina), confermando la loro sicurezza per l'uso in prodotti alimentari e bevande. Oobli ha anche completato un round di finanziamento Serie B1 da 18 milioni di dollari, con nuovi investitori strategici tra cui Ingredion Ventures, Lever VC e Sucden Ventures che si uniscono a investitori esistenti come Khosla Ventures e Piva Capital.
Le aziende presenteranno i loro nuovi dolci al Future Food Tech a San Francisco il 13-14 marzo 2025. Le proteine dolci di Oobli sono prodotte tramite fermentazione, offrendo un'alternativa economica e amica del clima ai dolcificanti tradizionali.
Oobli, la primera empresa en construir una plataforma de proteínas dulces, ha anunciado una asociación con Ingredion para acelerar el acceso de la industria a sistemas de edulcorantes más saludables. La colaboración tiene como objetivo combinar edulcorantes naturales como la stevia con las proteínas que endulzan de Oobli. Las proteínas dulces se pueden utilizar en varios alimentos y bebidas, incluidas refrescos, productos horneados, yogures y caramelos.
La asociación sigue a las recientes cartas de 'sin preguntas' GRAS de la FDA para dos proteínas dulces (monelina y brazzeína), confirmando su seguridad para su uso en productos alimenticios y bebidas. Oobli también ha completado una ronda de financiamiento Serie B1 de 18 millones de dólares, con nuevos inversores estratégicos, incluidos Ingredion Ventures, Lever VC y Sucden Ventures, que se unen a inversores existentes como Khosla Ventures y Piva Capital.
Las empresas mostrarán sus nuevos dulces en Future Food Tech en San Francisco del 13 al 14 de marzo de 2025. Las proteínas dulces de Oobli se producen a través de fermentación, ofreciendo una alternativa rentable y respetuosa con el clima a los edulcorantes tradicionales.
Oobli는 첫 번째 단백질 스위트 플랫폼을 구축한 회사로, Ingredion과의 파트너십을 발표하여 업계가 더 건강한 감미료 시스템에 접근할 수 있도록 가속화하고자 합니다. 이 협력은 스테비아와 Oobli의 단맛을 내는 단백질을 결합하는 것을 목표로 하고 있습니다. 단맛 단백질은 탄산음료, 구운 식품, 요거트 및 사탕 등 다양한 식품 및 음료에서 사용될 수 있습니다.
이번 파트너십은 Oobli가 두 가지 단맛 단백질(모넬린 및 브라제인)에 대해 FDA GRAS '질문 없음' 서신을 최근에 받은 후 이루어졌으며, 이는 이들이 식품 및 음료 제품에 사용하기에 안전하다는 것을 확인합니다. Oobli는 또한 1800만 달러 규모의 B1 시리즈 투자 라운드를 완료했으며, Ingredion Ventures, Lever VC 및 Sucden Ventures와 같은 새로운 전략적 투자자들이 Khosla Ventures 및 Piva Capital과 같은 기존 투자자들과 함께 참여했습니다.
이 회사들은 2025년 3월 13-14일 샌프란시스코에서 열리는 Future Food Tech에서 새로운 단맛 간식을 선보일 예정입니다. Oobli의 단맛 단백질은 발효를 통해 생산되어 전통적인 감미료에 대한 경제적이고 환경 친화적인 대안을 제공합니다.
Oobli, la première entreprise à construire une plateforme de protéines sucrées, a annoncé un partenariat avec Ingredion pour accélérer l'accès de l'industrie à des systèmes d'édulcorants plus sains. La collaboration vise à combiner des édulcorants naturels comme la stévia avec les protéines sucrées d'Oobli. Les protéines sucrées peuvent être utilisées dans divers aliments et boissons, y compris les sodas, les produits de boulangerie, les yaourts et les bonbons.
Ce partenariat fait suite aux récentes lettres 'sans questions' GRAS de la FDA pour deux protéines sucrées (monelline et brazzeïne), confirmant leur sécurité pour une utilisation dans les produits alimentaires et les boissons. Oobli a également complété un tour de financement de Série B1 de 18 millions de dollars, avec de nouveaux investisseurs stratégiques, y compris Ingredion Ventures, Lever VC et Sucden Ventures rejoignant des investisseurs existants comme Khosla Ventures et Piva Capital.
Les entreprises présenteront leurs nouvelles douceurs au Future Food Tech à San Francisco les 13 et 14 mars 2025. Les protéines sucrées d'Oobli sont produites par fermentation, offrant une alternative rentable et respectueuse du climat aux édulcorants traditionnels.
Oobli, das erste Unternehmen, das eine Plattform für süße Proteine entwickelt hat, hat eine Partnerschaft mit Ingredion angekündigt, um den Zugang der Industrie zu gesünderen Süßstoffsystemen zu beschleunigen. Die Zusammenarbeit zielt darauf ab, natürliche Süßstoffe wie Stevia mit Ooblis süßenden Proteinen zu kombinieren. Süße Proteine können in verschiedenen Lebensmitteln und Getränken verwendet werden, darunter Limonade, Backwaren, Joghurt und Süßigkeiten.
Die Partnerschaft folgt auf Ooblis kürzliche GRAS 'keine Fragen' Briefe von der FDA für zwei süße Proteine (Monellin und Brazzein), die ihre Sicherheit für den Einsatz in Lebensmitteln und Getränken bestätigen. Oobli hat außerdem eine Serie B1 Finanzierungsrunde über 18 Millionen Dollar abgeschlossen, bei der neue strategische Investoren wie Ingredion Ventures, Lever VC und Sucden Ventures zu bestehenden Investoren wie Khosla Ventures und Piva Capital gestoßen sind.
Die Unternehmen werden ihre neuartigen Süßigkeiten auf der Future Food Tech in San Francisco am 13. und 14. März 2025 präsentieren. Ooblis süße Proteine werden durch Fermentation hergestellt und bieten eine kostengünstige und klimafreundliche Alternative zu traditionellen Süßstoffen.
- Secured strategic partnership with major ingredient provider Ingredion
- Raised $18M in Series B1 funding from notable investors
- Received FDA GRAS approval for two sweet proteins
- First company globally regulated to sell sweet proteins as sweeteners
- None.
Insights
This strategic partnership represents a pivotal moment in the evolution of alternative sweeteners, combining Oobli's breakthrough sweet protein technology with Ingredion's established market presence and distribution network. The $18M Series B1 funding round, featuring strategic investors like Ingredion Ventures, validates the commercial viability of sweet proteins as a sugar alternative.
The collaboration's timing is particularly strategic, coinciding with intensifying global pressure for sugar reduction in food products and increasing consumer demand for natural sweeteners. Ingredion's expertise in stevia-based solutions creates powerful synergies - the ability to combine sweet proteins with stevia could solve long-standing challenges in taste profile and cost optimization that have historically the adoption of natural sweeteners.
Two critical factors differentiate this partnership: First, Oobli's unique position as the only company with FDA GRAS approval for sweet proteins as sweeteners provides a significant first-mover advantage in this emerging category. Second, the fermentation-based production method offers potential cost advantages and sustainability benefits compared to traditional sweetener sources.
For Ingredion, this partnership represents a strategic expansion of their sugar reduction portfolio, potentially positioning them at the forefront of the next generation of sweetener solutions. The company's established relationships with major food and beverage manufacturers could accelerate the commercial adoption of sweet protein technology, while their technical expertise in formulation could help overcome implementation challenges in various applications.
Ingredion Ventures, Lever VC, and Sucden Ventures join existing key investors to close an
"Sweet proteins are a long-overdue addition to the toolkit of better-for-you sweeteners," said Ali Wing, CEO at Oobli. "Working with Ingredion's best-in-class teams to pair natural sweeteners with our novel sweet proteins will deliver game-changing solutions in this important, growing and timely category."
Sweet proteins are a great-tasting, healthier sweetener that can be a foundational part of any combination of sweetener ingredients in food and beverages, including sodas, baked goods, yogurts, candies and more. Sweet proteins can also be used to cost effectively complement other natural sweeteners, helping food companies achieve ideal levels of sweetness, meet nutrition objectives and manage costs.
"We've long been at the forefront of innovation in sugar reduction solutions, and our work with sweet proteins is an exciting new chapter in that journey," said Nate Yates, VP and GM Sugar Reduction and Fiber Fortification, CEO Pure Circle at Ingredion. "Whether we're enhancing existing sweetener systems with sweet proteins or using our established sweeteners to unlock new possibilities, we see incredible synergies across these platforms."
Oobli and Ingredion recently tested several co-developed products to better understand the opportunities for sweet proteins and stevia. Both companies shared enthusiasm about the consumer feedback collected, which ultimately led to the partnership. Next month, the two companies will unveil some of these novel sweet treats at Future Food Tech in
This partnership news follows recent announcements by Oobli that it had received FDA GRAS "no questions" letters for two sweet proteins (monellin and brazzein), confirming that these novel sweet proteins are safe to be used as a sweetener in food and beverage products.
In addition to their latest regulatory and partnership announcements, Oobli has also recently completed
This round supports Oobli's expansion across food and beverages with sweet proteins, both as a standalone solution, as well as in combination with other natural sweeteners, such as stevia, developed in partnership with Ingredion.
About Oobli
Oobli is a sweet protein technology platform company focused on replacing sugar in food and beverages. Sweet proteins have no glycemic impact or effect on the gut microbiome. Produced via fermentation, Oobli sweet proteins are both cost-effective as a sweetener replacement and climate friendly, saving massive amounts of land, water and carbon compared to farmed sugarcane. Oobli is the first and only company in the world regulated to sell sweet proteins as a sweetener, with two FDA "no questions" letters, four proteins with self-affirmed FDA GRAS status and one protein with FDA FEMA GRAS status. In addition to selling its own protein-sweetened chocolates, Oobli partners with companies to help deliver great-tasting, affordable and healthier products. For more information, visit oobli.com.
About Ingredion
Ingredion Incorporated (NYSE: INGR) headquartered in the suburbs of
Media Contact
press@oobli.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/oobli-and-ingredion-announce-partnership-as-demand-for-sweet-proteins-accelerates-302375717.html
SOURCE Oobli
FAQ
What is the value of Oobli's Series B1 funding round announced in February 2025?
Which sweet proteins received FDA GRAS approval for Oobli's sweetener platform?
When will Oobli and Ingredion showcase their new sweet protein products?
What are the environmental benefits of Oobli's sweet protein technology?
What types of products can incorporate Oobli's sweet proteins?
